AUG 17, 2026 · JOURNAL ARTICLE
From pathogen to “living drug factory” innovative strategies and clinical translation of bacteria as programmable intelligent vectors for cancer therapy
Bmemat
This is a narrative review synthesizing preclinical concepts, mechanistic insights, and early translational work on engineered bacteria for cancer therapy; it raises questions and explores possibilities rather than reporting a primary clinical trial result or definitive evidence.